Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

AI Notetakers For Doctors Raise 'Bycatching' Liability Risks No Photo Available

Busy doctors have embraced AI-powered devices that record patient conversations and generate visit notes. The expansion of ambient not... (more story)

Healthcare Deals This Week: AstraZeneca, Novartis, Vertex No Photo Available

Despite a short week, healthcare dealmakers were busy at work, as Law360 counted at least four billion-dollar transactions involving n... (more story)

HHS Swerves After Ruling On RFK Jr.'s Gender Edict No Photo Available

The Trump administration wants a federal judge to amend a decision blocking a policy declaration by Health and Human Services Secretar... (more story)